Page 328 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Autoimmune and Hepato Biliary Disease (Cont.)

YI P1206 ANTI-INFLAMMATORY AND DIRECT ANTIFIBROTIC
EFFECT OF ORAL HEPATOTROPICDPP4INHIBITORS IN
MODELS OF NASH AND BILARY FIBROSIS
Xiao-Yu Wang*, Shih-Yen Weng, Thomas Klein,Yong Ook Kim,
Detlef Schuppan, Germany

YI P1207 FATIGUE IN PRIMARY BILIARY CIRRHOSIS: SIMILAR
PREVALENCE TO THE POPULATION FROM THE
SAME GEOGRAPHIC AREA, AND ASSOCIATION WITH
COMORBIDITIES AND SEVERITY OF CHOLESTASIS
Anna Reig*, Pilar Sesé, Sabela Lens, Llorenç Caballeria, Albert Pares,
Spain

YI P1208 ANALYSIS OF HUMORAL IMMUNE RESPONSE IN A NEW
ANIMAL MODEL OF AUTOIMMUNE HEPATITIS: NEW
ANTIGENS IDENTIFICATION
Mercedes Blasi*, Irene Gil-Fariña, Marianna Di Scala, Jesús Prieto,
María González, Paula Díez, Manuel Fuentes, Gloria González-
Aseguinolaza, Spain

ePOSTERS YI P1209 CORONARY MICROVASCULAR DYSFUNCTION IN
PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WITHOUT
METABOLIC SYNDROME: A HINT FOR THEIR INCREASED
CARDIOVASCULAR RISK
Nora Cazzagon*, Carlo Dal Lin, Giulia Famoso, Irene Franceschet,
Annarosa Floreani, Francesco Tona, Italy

YI P1210 IMPACT OF SPECIALIST PATHOLOGY REVIEW OF LIVER
BIOPSIES ON THE FINAL DIAGNOSIS AND PATIENT
MANAGEMENT
Anna Paterson*, Michael Allison, Rebecca Brais, Susan Davies,
The United Kingdom

328 The International Liver Congress™ 2015 • ILC Programme